Reviewed,
UniProtKB/Swiss-Prot O14639 (ABLM1_HUMAN)
Last modified
December 16, 2008.
Version 78.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Actin-binding LIM protein 1 Alternative name(s): Actin-binding LIM protein family member 1 Short name=abLIM-1 Actin-binding double zinc finger protein LIMAB1 Limatin | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 778 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May act as scaffold protein By similarity. May play a role in the development of the retina. Has been suggested to play a role in axon guidance. |
| Subunit structure | Binds F-actin. Interacts with ABRA. Ref.7 |
| Subcellular location | CytoplasmBy similarity. Cytoplasm › cytoskeletonBy similarity. Note= Associated with the cytoskeleton By similarity. |
| Tissue specificity | Detected in liver, heart, skeletal muscle, brain and retina, where it is concentrated in the inner segment and in the outer plexiform layers. Ref.1 |
| Post-translational modification | Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 |
| Sequence similarities | Contains 1 HP (headpiece) domain. Contains 4 LIM zinc-binding domains. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cytoplasm Cytoskeleton |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Coiled coil LIM domain Repeat |
| Ligand | Actin-binding Metal-binding Zinc |
| PTM | Phosphoprotein |
Gene Ontology (GO) | |
| Biological process | cytoskeleton organization Inferred from electronic annotation. Source: InterPro organ morphogenesis Ref.1Traceable author statement. Source: ProtInc visual perception Ref.1Traceable author statement. Source: ProtInc |
| Cellular component | actin cytoskeleton Ref.1 Traceable author statement. Source: ProtInc cytoplasmInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | actin binding Ref.1 Traceable author statement. Source: ProtInc zinc ion bindingInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O14639-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O14639-2) The sequence of this isoform differs from the canonical sequence as follows: 1-81: MPAFLGLKCL...GRVCNSVDPF → MLMTLEMTELTDPHHTMGDYK | ||||||
| Isoform 3 (identifier: O14639-3) The sequence of this isoform differs from the canonical sequence as follows: 1-316: Missing. 480-514: Missing. | ||||||
| Isoform 4 (identifier: O14639-4) The sequence of this isoform differs from the canonical sequence as follows: 1-316: Missing. 348-373: Missing. 480-514: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 778 | 778 | Actin-binding LIM protein 1 | PRO_0000075697 | |||||
Regions | |||||||||
| Domain | 97 – 156 | 60 | LIM zinc-binding 1 | ||||||
| Domain | 156 – 216 | 61 | LIM zinc-binding 2 | ||||||
| Domain | 224 – 283 | 60 | LIM zinc-binding 3 | ||||||
| Domain | 283 – 343 | 61 | LIM zinc-binding 4 | ||||||
| Domain | 710 – 778 | 69 | HP | ||||||
| Coiled coil | 590 – 614 | 25 | Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 216 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 353 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 357 | 1 | Phosphotyrosine Ref.8 | ||||||
| Modified residue | 367 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 373 | 1 | Phosphotyrosine Ref.8 | ||||||
| Modified residue | 396 | 1 | Phosphotyrosine Ref.10 | ||||||
| Modified residue | 406 | 1 | Phosphotyrosine Ref.10 | ||||||
| Modified residue | 410 | 1 | Phosphotyrosine Ref.10 | ||||||
| Modified residue | 431 | 1 | Phosphoserine Ref.9 Ref.14 Ref.15 | ||||||
| Modified residue | 435 | 1 | Phosphoserine Ref.8 Ref.15 | ||||||
| Modified residue | 439 | 1 | Phosphotyrosine Ref.8 | ||||||
| Modified residue | 450 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 452 | 1 | Phosphoserine Ref.9 Ref.13 | ||||||
| Modified residue | 455 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 458 | 1 | Phosphoserine Ref.13 Ref.15 | ||||||
| Modified residue | 461 | 1 | Phosphotyrosine Ref.8 Ref.11 | ||||||
| Modified residue | 473 | 1 | Phosphoserine Ref.12 | ||||||
| Modified residue | 587 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 640 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 655 | 1 | Phosphoserine Ref.9 Ref.15 | ||||||
| Modified residue | 706 | 1 | Phosphoserine Ref.9 Ref.15 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 316 | 316 | Missing in isoform 3 and isoform 4. | VSP_012099 | |||||
| Alternative sequence | 1 – 81 | 81 | MPAFL…SVDPF → MLMTLEMTELTDPHHTMGDY K in isoform 2. | VSP_012100 | |||||
| Alternative sequence | 348 – 373 | 26 | Missing in isoform 4. | VSP_012101 | |||||
| Alternative sequence | 480 – 514 | 35 | Missing in isoform 3 and isoform 4. | VSP_012102 | |||||
| Natural variant | 434 | 1 | P → T: dbSNP rs11593544. | VAR_050141 | |||||
| Natural variant | 637 | 1 | R → G: dbSNP rs7091419. | VAR_050142 | |||||
Experimental info | |||||||||
| Sequence conflict | 499 | 1 | R → L in AAC51676. Ref.1 | ||||||
| Sequence conflict | 532 | 1 | A → R in AAC51676. Ref.1 | ||||||
| Sequence conflict | 563 | 1 | K → E in BAA06681. Ref.2 | ||||||
| Sequence conflict | 578 | 1 | V → I in BAA06681. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein." Roof D.J., Hayes A., Adamian M., Chishti A.H., Li T. J. Cell Biol. 138:575-588(1997) [PubMed: 9245787] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ALTERNATIVE SPLICING, TISSUE SPECIFICITY. Tissue: Retina. |
| [2] | "Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1." Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S., Seki N., Kawarabayasi Y., Ishikawa K., Tabata S. DNA Res. 1:223-229(1994) [PubMed: 7584044] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Bone marrow. |
| [3] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed: 12168954] [Abstract] Cited for: SEQUENCE REVISION. |
| [4] | The German cDNA consortium Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Retina. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed: 15164054] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Kidney. |
| [7] | "Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin." Barrientos T., Frank D., Kuwahara K., Bezprozvannaya S., Pipes G.C.T., Bassel-Duby R., Richardson J.A., Katus H.A., Olson E.N., Frey N. J. Biol. Chem. 282:8393-8403(2007) [PubMed: 17194709] [Abstract] Cited for: INTERACTION WITH ABRA. |
| [8] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed: 15144186] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-357; TYR-373; SER-435; TYR-439 AND TYR-461, MASS SPECTROMETRY. Tissue: T-cell. |
| [9] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-452; SER-655 AND SER-706, MASS SPECTROMETRY. Tissue: Epithelium. |
| [10] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-396; TYR-406 AND TYR-410, MASS SPECTROMETRY. |
| [11] | "Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry." Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J., Bodenmiller B., Watts J.D., Hood L., Aebersold R. Nat. Methods 2:591-598(2005) [PubMed: 16094384] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-461, MASS SPECTROMETRY. Tissue: T-cell. |
| [12] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-452 AND SER-458, MASS SPECTROMETRY. |
| [14] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, MASS SPECTROMETRY. Tissue: Platelet. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435; SER-455; SER-458; SER-587; SER-640; SER-655 AND SER-706, MASS SPECTROMETRY. |

Clusters with